Lv3
348 积分 2022-04-19 加入
科研有趣，有趣科研
Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors
10天前
已完结
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience
10天前
已完结
Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced Cancer
10天前
已完结
Safe Anti-Programmed Cell Death-1 Rechallenge With Antibody Switching After Immune-Related Adverse Events: Brief Communication
11天前
已关闭
Safe Anti-Programmed Cell Death-1 Rechallenge With Antibody Switching After Immune-Related Adverse Events: Brief Communication
11天前
已关闭
Non-small-cell lung cancer
13天前
已完结
PCSK9 inhibition ameliorates experimental autoimmune myocarditis by reducing Th17 cell differentiation through LDLR/STAT-3/ROR-γt pathway
25天前
已完结
Autoimmune Myocarditis, Old Dogs and New Tricks
25天前
已完结
Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti–PD-1–Based Immunotherapy as Curative-Intent Treatment
1个月前
已完结
Uveal melanoma: In the era of new treatments
3个月前
已完结
皖公网安备34019202002308
